KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to -$200000.0.

  • Emergent BioSolutions' Exchange Rate Effect changed N/A to -$200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 10666.67%. This contributed to the annual value of -$1.2 million for FY2023, which is 34000.0% down from last year.
  • Emergent BioSolutions' Exchange Rate Effect amounted to -$200000.0 in Q3 2025.
  • Emergent BioSolutions' 5-year Exchange Rate Effect high stood at $1.1 million for Q4 2022, and its period low was -$1.5 million during Q4 2023.
  • For the 4-year period, Emergent BioSolutions' Exchange Rate Effect averaged around -$64285.7, with its median value being -$200000.0 (2021).
  • In the last 5 years, Emergent BioSolutions' Exchange Rate Effect crashed by 40000.0% in 2021 and then soared by 25000.0% in 2022.
  • Quarter analysis of 4 years shows Emergent BioSolutions' Exchange Rate Effect stood at -$200000.0 in 2021, then skyrocketed by 650.0% to $1.1 million in 2022, then plummeted by 236.36% to -$1.5 million in 2023, then surged by 86.67% to -$200000.0 in 2025.
  • Its Exchange Rate Effect stands at -$200000.0 for Q3 2025, versus $1.0 million for Q2 2025 and -$700000.0 for Q1 2025.